Oragenics OGEN
NYSE OGEN
$0.53 -0.01 (-1.60%)
As of: Aug 21, 2026 · 12:13 PM EDT

Oragenics (OGEN) Operating Margin Growth (3y) (2013 - 2014)

Oragenics (OGEN) Operating Margin Growth (3y) (2013 - 2014) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Vertex Pharmaceuticals 139.71 Bn 131.86 Bn 2.84 Bn -377.00
2 Regeneron Pharmaceuticals 86.55 Bn 78.55 Bn 3.93 Bn -204.00
3 Argenx Se 65.26 Bn 60.07 Bn 1.37 Bn -537.00
4 Moderna 59.81 Bn 54.67 Bn 52.00 Mn -1,934.00
5 BeOne Medicines 42.16 Bn 37.06 Bn 1.53 Bn 7,261.00
6 Alnylam Pharmaceuticals 31.87 Bn 28.56 Bn 992.69 Mn 9,003.00
7 BioNTech SE 28.13 Bn 9.74 Bn 668.28 Mn -11,254.00
8 Insmed 27.53 Bn 26.37 Bn 358.27 Mn 30,461.00
9 Royalty Pharma 27.31 Bn 26.47 Bn - -2,649.00
10 Oragenics 2.35 Mn 2.35 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2014 -10,012.00
Sep 30, 2014 -2,643.00
Jun 30, 2014 3,666.00
Mar 31, 2014 -33,513.00
Dec 31, 2013 5,596.00
Sep 30, 2013 -316,742.00
Jun 30, 2013 -57,832.00